tradingkey.logo
tradingkey.logo
Search

Prime Medicine Inc

PRME
Add to Watchlist
3.015USD
+0.065+2.20%
Close 07-27 16:00ETQuotes delayed by 15 min
544.56MMarket Cap
LossP/E TTM

PRME Financials

See Prime Medicine Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Prime Medicine Inc Earnings Date

Latest Release
May 7, 2026
EPS / Forecast
-0.28/-0.25
Revenue / Forecast
856.00K/1.07M
Period
FY2025 Earnings
Revenue(YoY)
4.63M
55.28%
EPS(YoY)
-1.35
18.13%
Analyst Rating
BUY
2026/07/27
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
30.04%-0.28
19.51%-0.26
28.13%-0.32
12.30%-0.41
9.49%-0.40
54.51%-0.32
20.57%-0.44
0.92%-0.46
0.97%-0.44
-85.06%-0.71
---0.55
---0.47
---0.44
---0.38
---1.08
----
----
----
----
----
Revenue
-41.13%856.00K
-61.61%838.00K
486.12%1.23M
--1.11M
146.02%1.45M
--2.18M
--209.00K
--0.00
--591.00K
----
----
----
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
Net Profit
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-61.69%-65.64M
-41.99%-50.71M
-18.92%-42.38M
-31.04%-39.40M
41.40%-40.60M
-56.80%-35.71M
-745.17%-35.64M
65.78%-30.06M
-1970.32%-69.27M
---22.77M
---4.22M
Net Margin
-60.80%-5738.55%
-183.93%-5498.69%
83.57%-4129.14%
---4716.68%
53.91%-3568.78%
---1936.60%
---25128.23%
----
---7742.98%
----
----
----
----
----
----
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
0.00%100.00%
--100.00%
--100.00%
----
--100.00%
----
----
----
----
----
----
----
----
----
----
----
Revenue
-41.13%856.00K
-61.61%838.00K
486.12%1.23M
--1.11M
146.02%1.45M
--2.18M
--209.00K
--0.00
--591.00K
----
----
----
----
--0.00
----
--0.00
--0.00
--0.00
--0.00
--0.00
Operating profit
3.32%-50.65M
-9.92%-48.61M
0.48%-53.97M
4.12%-53.38M
-8.38%-52.39M
35.01%-44.22M
-5.39%-54.23M
-23.01%-55.67M
-20.75%-48.34M
-75.89%-68.04M
-62.56%-51.46M
-72.05%-45.26M
-101.19%-40.03M
35.60%-38.69M
-203.59%-31.66M
-228.16%-26.30M
-234.14%-19.90M
-2213.28%-60.08M
---10.43M
---8.02M
Net Profit
5.33%-49.12M
-9.00%-46.08M
3.69%-50.58M
4.95%-52.59M
-13.39%-51.89M
35.60%-42.28M
-3.57%-52.52M
-30.53%-55.33M
-16.15%-45.76M
-61.69%-65.64M
-41.99%-50.71M
-18.92%-42.38M
-31.04%-39.40M
41.40%-40.60M
-56.80%-35.71M
-745.17%-35.64M
65.78%-30.06M
-1970.32%-69.27M
---22.77M
---4.22M
Current assets
-15.80%137.89M
-14.44%181.29M
-5.96%231.41M
-28.99%121.29M
-24.76%163.76M
48.20%211.89M
33.35%246.07M
-21.83%170.80M
-14.14%217.65M
-51.80%142.98M
23.98%184.53M
20.31%218.49M
19.60%253.50M
9.62%296.62M
-50.45%148.84M
--181.60M
--211.96M
--270.58M
--300.41M
----
Total current liabilities
5.84%36.29M
-1.35%37.45M
-7.55%35.02M
64.39%34.11M
40.29%34.29M
-32.72%37.96M
-3.78%37.88M
-27.76%20.75M
2.39%24.44M
111.21%56.42M
77.18%39.37M
20.51%28.72M
85.19%23.87M
-53.93%26.71M
132.80%22.22M
--23.83M
--12.89M
--57.98M
--9.54M
----
Total assets
-10.19%294.73M
15.20%342.73M
15.69%385.01M
7.43%279.01M
5.39%328.16M
53.47%297.51M
39.16%332.78M
-7.53%259.70M
-1.76%311.38M
-46.20%193.85M
11.09%239.15M
13.44%280.87M
29.60%316.95M
19.37%360.31M
-31.70%215.26M
--247.60M
--244.55M
--301.86M
--315.19M
----
Total liabilities
-1.45%218.03M
53.69%221.87M
55.77%223.19M
245.63%218.15M
227.19%221.24M
137.51%144.36M
217.08%143.28M
54.84%63.12M
77.26%67.62M
38.00%60.78M
6.17%45.19M
-13.01%40.76M
143.07%38.15M
-29.30%44.04M
208.16%42.56M
--46.86M
--15.69M
--62.30M
--13.81M
----
Total equity
-28.27%76.70M
-21.08%120.87M
-14.61%161.82M
-69.04%60.86M
-56.14%106.92M
15.09%153.15M
-2.30%189.50M
-18.12%196.59M
-12.57%243.77M
-57.92%133.07M
12.31%193.96M
19.61%240.10M
21.82%278.80M
32.02%316.27M
-42.70%172.70M
--200.74M
--228.86M
--239.56M
--301.38M
----
Net operating income
12.58%-42.71M
-329.34%-37.26M
-35.22%-35.04M
8.97%-41.41M
27.84%-48.86M
137.03%16.25M
33.84%-25.91M
-11.44%-45.49M
-62.91%-67.71M
-42.82%-43.86M
-30.13%-39.17M
-101.85%-40.82M
18.18%-41.56M
-132.90%-30.71M
-213.33%-30.10M
-215.39%-20.22M
-941.48%-50.79M
-430.45%-13.19M
---9.61M
---6.41M
Net investment
190.89%43.39M
-41.29%28.33M
-282.99%-92.12M
-59.81%2.77M
-28.92%-47.74M
16.88%48.25M
233.29%50.34M
-75.26%6.89M
-192.40%-37.03M
401.64%41.28M
-179.55%-37.77M
154.85%27.86M
-141.00%-12.66M
-212.61%-13.69M
-76.94%-13.51M
34.18%-50.79M
3278.29%30.89M
3514.04%12.15M
---7.64M
---77.17M
Net financing
-93.45%393.00K
56100.00%562.00K
275.85%144.75M
462.86%197.00K
-96.19%6.00M
-99.48%1.00K
12011.01%38.51M
-53.33%35.00K
231263.24%157.33M
-99.89%194.00K
146.56%318.00K
112.02%75.00K
105.35%68.00K
17049.63%184.07M
-68200.00%-683.00K
-100.23%-624.00K
-154.99%-1.27M
-103.11%-1.09M
---1.00K
--268.05M

FAQs

What is the total revenue of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its total revenue reached 4.63M, with a year-on-year change of 2.98M.

What are the current assets of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its current assets were 181.29M, with a year-on-year change of -14.44.

What are the total assets of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its total assets of Prime Medicine Inc were 342.73M, with a year-on-year change of 15.20.

What are the total liabilities of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its total liabilities of Prime Medicine Inc were 221.87M, with a year-on-year change of 53.69.

What is the total equity of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its total equity of Prime Medicine Inc was 120.87M, with a year-on-year change of -21.08.

What is the net operating income of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its net operating income of Prime Medicine Inc was -208.35M, with a year-on-year change of -2.91.

What is the net investment of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its net investment of Prime Medicine Inc was -108.76M, with a year-on-year change of -258.88.

What is the net financing of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its net financing of Prime Medicine Inc was 151.51M, with a year-on-year change of -22.65.

What is the Earnings Per Share (EPS) of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -1.35, with a year-on-year change of 18.13.

What is the net income of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its net income was -201.14M, with a year-on-year change of -2.69.

What is the net margin of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its net profit margin was -4342.44, with a year-on-year change of 33.87.

What is the Return on Equity (ROE) of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its Return on Equity (ROE) was -146.81, with a year-on-year change of -7.26.

What is the Return on Assets (ROA) of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its Return on Assets (ROA) was -62.83, with a year-on-year change of 21.19.

What is the operating profit of Prime Medicine Inc?

According to Prime Medicine Inc's FY2025 earnings report, its operating profit was -208.35M, with a year-on-year change of -2.91.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.